NASDAQ: IMRX - Immuneering Corporation

六个月盈利: +113.76%
股息率: 0.00%
部门: Healthcare

促销时间表 Immuneering Corporation

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Immuneering Corporation

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 currently in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2021-07-30
ISIN US45254E1073
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://immuneering.com
Цена ао 2.39
每日价格变化: +6.88% (2.18)
每周价格变化: +16.5% (2)
每月价格变化: +9.39% (2.13)
3个月内价格变化: -12.41% (2.66)
六个月内的价格变化: +113.76% (1.09)
每年价格变化: -68.3% (7.35)
3年内价格变化: -88.9% (20.99)
5年内价格变化: 0% (2.33)
10年价格变化: 0% (2.33)
年初以来价格变化: +29.44% (1.8)
所有参数

低估

姓名 意义 年级
P/S 467155.72 1
P/BV 2.35 6
P/E 0 0
EV/EBITDA -2.73 0
全部的: 3.5

效率

姓名 意义 年级
ROA, % -52.12 0
ROE, % -59.03 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0774 10
全部的: 8.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -99.98 0
盈利能力 Ebitda, % 695.35 10
盈利能力 EPS, % 100.27 10
全部的: 8
更多详情

机构 体积 分享, %
Cormorant Asset Management, LP 4204364 14.36
Price (T.Rowe) Associates Inc 3378100 11.54
Blackrock Inc. 2097406 7.16
Citadel Advisors Llc 2078092 7.1
Vanguard Group Inc 1073815 3.67
FMR, LLC 489447 1.67
Goldman Sachs Group Inc 457059 1.56
Geode Capital Management, LLC 444233 1.52
State Street Corporation 373662 1.28
HighVista Strategies LLC 254513 0.87

ETF 分享, % 本年盈利能力, % 股息, %
Range Cancer Therapeutics ETF 1.07445 47.24 0.11955
iShares Micro-Cap ETF 0.01885 17.09 1.54048



导师 职称 支付 出生年份
Dr. Benjamin J. Zeskind M.B.A., Ph.D. Co-Founder, President, CEO & Director 935.09k 1983 (42 年)
Dr. Brett M. Hall Ph.D. Chief Scientific Officer 905.41k 1969 (56 年)
Ms. Mallory Morales CPA Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer N/A 1984 (41 年)
Ms. Paula George CPA Director of Accounting & Operations and Assistant Corporate Controller N/A
Mr. Michael D. Bookman J.D. Chief Legal Officer & Secretary N/A 1987 (38 年)
Ms. Leah R. Neufeld Chief People Officer N/A 1973 (52 年)
Dr. Peter King Ph.D. Head of Discovery & VP N/A
Dr. Praveen Nair Ph.D. Head of Translational Pharmacology & VP N/A
Mr. Harold E. Brakewood Chief Business Officer 579.77k 1966 (59 年)
Mr. Robert J. Carpenter M.B.A., M.S. Co-Founder & Chair Emeritus 75.36k 1946 (79 年)

地址: United States, Cambridge. MA, 245 Main Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://immuneering.com